STOCK TITAN
  1. Home
  2. Sec-filings
  3. AAPG
  4. [Form 3/A] ASCENTAGE PHARMA GROUP INTERNATIONAL Amended Initial Statement of Beneficial Ownership

AAPG (AAPG) accounting officer reports 5,400 shares and 12,883 RSUs

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
3/A

Rhea-AI Filing Summary

ASCENTAGE PHARMA GROUP INTERNATIONAL filed an amended insider ownership report for Chief Accounting Officer Jin Cao. The filing shows direct ownership of 5,400 Ordinary Shares, which had been inadvertently omitted previously, and 12,883 restricted stock units (RSUs).

Each RSU represents a contingent right to receive one Ordinary Share upon vesting. The RSUs vest in four equal installments on November 26 of 2026, 2027, 2028 and 2029, and do not have an expiration date.

Positive

  • None.

Negative

  • None.
Insider Cao Jin
Role Chief Accounting Officer
Type Security Shares Price Value
holding Restricted stock units -- -- --
holding Ordinary Shares -- -- --
Holdings After Transaction: Restricted stock units — 12,883 shares (Direct, null); Ordinary Shares — 5,400 shares (Direct, null)
Footnotes (1)
  1. The ordinary shares held by the Reporting Person were inadvertently not included. Each restricted stock unit (RSUs) represents a contingent right to receive one Ordinary Share of the Issuer upon vesting. The RSUs vest in four equal increments on each of 11/26/2026, 2027, 2028 and 2029 and have no expiration date.
Ordinary Shares held 5,400 shares Direct ownership reported for Jin Cao
Restricted stock units 12,883 RSUs RSUs convertible into Ordinary Shares upon vesting
RSU vesting schedule 4 equal installments Vesting on Nov 26 of 2026, 2027, 2028 and 2029
Restricted stock units financial
"Each restricted stock unit (RSUs) represents a contingent right to receive one Ordinary Share"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
contingent right financial
"represents a contingent right to receive one Ordinary Share of the Issuer upon vesting"
vesting financial
"The RSUs vest in four equal increments on each of 11/26/2026, 2027, 2028 and 2029"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
Understanding Insider Trading Forms →
SEC Form 3
FORM 3UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0104
Estimated average burden
hours per response:0.5
1. Name and Address of Reporting Person*
Cao Jin
(Last)(First)(Middle)
700 KING FARM BOULEVARD
SUITE 510
(Street)
ROCKVILLE MARYLAND 20850
(City)(State)(Zip)
UNITED STATES
(Country)		2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026		3. Issuer Name and Ticker or Trading Symbol
ASCENTAGE PHARMA GROUP INTERNATIONAL [ AAPG ]
3a. Foreign Trading Symbol
5. If Amendment, Date of Original Filed (Month/Day/Year)
04/10/2026
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Accounting Officer
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares5,400D(1)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year)3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted stock units (2) (2)Ordinary Shares12,883$0D
Explanation of Responses:
1. The ordinary shares held by the Reporting Person were inadvertently not included.
2. Each restricted stock unit (RSUs) represents a contingent right to receive one Ordinary Share of the Issuer upon vesting. The RSUs vest in four equal increments on each of 11/26/2026, 2027, 2028 and 2029 and have no expiration date.
Remarks:
This form is filed using a special power of attorney.
Thomas J. Knapp04/20/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider holdings does AAPG Chief Accounting Officer Jin Cao report in this Form 3/A?

Jin Cao reports direct ownership of 5,400 Ordinary Shares of ASCENTAGE PHARMA GROUP INTERNATIONAL and 12,883 restricted stock units (RSUs). The Form 3/A corrects an earlier omission where the ordinary shares were inadvertently not included in prior disclosure.

How do the restricted stock units reported for AAPG’s Jin Cao vest?

The 12,883 RSUs vest in four equal increments on November 26 of 2026, 2027, 2028 and 2029. As each portion vests, it converts into the right to receive one Ordinary Share per RSU, supporting long-term equity compensation.

What does each RSU represent for ASCENTAGE PHARMA (AAPG) Chief Accounting Officer Jin Cao?

Each restricted stock unit represents a contingent right to receive one Ordinary Share of ASCENTAGE PHARMA GROUP INTERNATIONAL upon vesting. This means Jin Cao’s RSUs turn into ordinary shares over time as vesting milestones are reached.

Why was this Form 3/A amendment filed for AAPG’s Jin Cao?

The amendment states that the ordinary shares held by the reporting person “were inadvertently not included” previously. Form 3/A therefore corrects Jin Cao’s reported holdings to show both the 5,400 Ordinary Shares and 12,883 RSUs accurately.

Do the RSUs held by AAPG’s Jin Cao have an expiration date?

The filing explains that the restricted stock units have no expiration date. They vest in four equal annual installments starting November 26, 2026. Once vested, each RSU entitles Jin Cao to receive one Ordinary Share of the issuer.